世界の抗ウイルス薬治療市場の規模は2031年までにxx億ドルに達し、予測期間中は高いCAGRで拡大する見込みです。HIV、インフルエンザ、ヘルペス、肝炎、その他のウイルスを含むウイルス性疾患の蔓延が、抗ウイルス薬治療の需要を促進する主な要因です。市場の成長を後押しする他の主な推進要因としては、高齢者人口の増加、抗ウイルス薬の研究開発の進歩;抗ウイルス薬市場の戦略的政策の強化、新興経済国における医療インフラの整備が挙げられます。 さらに、COVID-19パンデミックは、抗ウイルス薬治療市場に大きな影響を及ぼしています。したがって予測期間中は抗ウイルス薬治療の需要は増加すると予想されます。
目次
1. Report Overview
1.1 Introduction to Antiviral Drugs Treatment Market
1.2 Antiviral Drugs Treatment Market Definition
1.3 Why You Should Read This Report
1.4 What This Report Delivers
1.5 Key Questions Answered By This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 Primary Research
1.7.2 Secondary Research
1.7.3 Market Evaluation & Forecasting Methodology
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2 Executive Summary
3 Market Dynamics
3.1 Drivers
3.1.1 Increasing Incidence of Viral Diseases to drive market growth
3.1.2 Increasing Geriatric Population is projected to propel the Demand for Anti-Viral Drugs
3.1.3 Advancement in Anti-Viral Drugs R&D is driving the Market Growth
3.1.4 Rising Strategic Initiatives for Anti-Viral Drugs Market is another Major Factor Propelling the Market Growth
3.2 Restraints
3.2.1 Stringent Regulations Associated with Product Approval Hinders the Market Growth
3.2.2 High Costs of Drug Development Limits the Entry of New Players
3.2.3 Rising Prevalent Resistance to Neuraminidase Inhibitors
3.3 Opportunities
3.3.1 Increasing Corona Virus Disease Emerge Need for Anti-Viral Drugs
3.3.2 M&A and Collaboration by the leading Vendors Provide Opportunity to Grow in the Market
3.4 Porter's Five Forces Analysis
3.4.1 Bargaining Power of Supplier: Moderate
3.4.2 Bargaining Power of Buyer: Moderate
3.4.3 Competitive Rivalry: High
3.4.4 Threat of New Entrants: Moderate
3.4.5 Threat of Substitutes: Moderate
3.5 PEST Analysis
3.5.1 Political Factors Impacting Antiviral Drugs Treatment Market
3.5.2 Economic Factors Impacting Anti-Viral Drugs Market
3.5.3 Social Factors Impacting Anti-Viral Drugs Market
3.5.4 Technological Factors Impacting Anti-Viral Drugs Market
4 Antiviral Drugs Treatment Market by Drug Class Forecast, 2021-2031
4.1 Reverse Transcriptase Inhibitors Segment Market Forecast, 2021-2031
4.1.1 The reverse-transcriptase inhibitors are class of antiretroviral drugs, majorly used to treat HIV infection and Hepatitis B
4.1.2 Global Antiviral Drugs Treatment Market for Reverse Transcriptase Inhibitors Segment Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
4.2 Protease Inhibitors Segment Market Forecast, 2021-2031
4.2.1 The Antiretroviral protease inhibitors bind the catalytic site of the HIV protease
4.2.2 Global Antiviral Drugs Treatment Market for Protease Inhibitors Segment Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
4.3 DNA Polymerase Inhibitors Segment Market Forecast, 2021-2031
4.3.1 Inhibiting DNA synthesis is significant therapeutic strategy, widely used to treat the viral infections
4.3.2 Global Antiviral Drugs Treatment Market for DNA Polymerase Inhibitors Segment Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
4.4 Neuraminidase Transcriptase Inhibitors Segment Market Forecast, 2021-2031
4.4.1 Growing Public awareness, boost in the Research and Development segment swelling interest to support the development of new Antiviral drugs
4.4.2 Global Antiviral Drugs Treatment Market for Neuraminidase Inhibitors Segment Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
4.5 Others Segment Market Forecast, 2021-2031
4.5.1 Other Essential Inhibitors
4.5.2 Global Antiviral Drugs Treatment Market for Others Segment Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
5 Antiviral Drugs Treatment Market by Application Forecast, 2021-2031
5.1 Hepatitis Segment Market Forecast, 2021-2031
5.1.1 Largest Revenue Grossing Segment / Hepatitis C Virus (HCV) is transmitted through infective blood exposure, or by HCV contaminated blood and blood products
5.1.2 Global Antiviral Drugs Treatment Market for Hepatitis Segment Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
5.2 HIV Segment Market Forecast, 2021-2031
5.2.1 HIV needs protease to replicate, which includes atazanavir, darunavir, fosamprenavir, and lopinavir
5.2.2 Global Antiviral Drugs Treatment Market for HIV Segment Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
5.3 Influenza Inhibitors Segment Market Forecast, 2021-2031
5.3.1 The neuraminidase inhibitors (oseltamivir, zanamivir, laninamivir and peramivir) and M2 protein inhibitors are class of antiviral drugs to treat viral infection
5.3.2 Global Antiviral Drugs Treatment Market for Influenza Segment Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
5.4 Herpes Segment Market Forecast, 2021-2031
5.4.1 Herpes is caused by Herpes simplex virus (HSV), which develops sores or blisters to form in or around the mouth or genitals
5.4.2 Global Antiviral Drugs Treatment Market for Herpes Segment Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
5.5 Others Segment Market Forecast, 2021-2031
5.5.1 Growing Demand for Advanced Drugs Is Expected to Propel the Segment Growth
5.5.2 Global Antiviral Drugs Treatment Market for Others Segment Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
6 Antiviral Drugs Treatment Market by End User Forecast, 2021-2031
6.1 Hospital Segment Market Forecast, 2021-2031
6.1.1 Pandemic emerge the demand for antiviral drugs
6.1.2 Global Antiviral Drugs Treatment Market for Hospital Segment Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
6.2 Clinics Segment Market Forecast, 2021-2031
6.2.1 Increasing use of antiviral drugs for primary treatment include hepatitis B, herpes virus and Influenza virus
6.2.2 Global Antiviral Drugs Treatment Market for Clinics Segment Forecast 2021-2031: Recovery Scenarios (V, U, W, L)
6.3 Others Segment Market Forecast, 2021-2031
6.3.1 The Research Institutes Specialize in the Field of Viral Infection
6.3.2 Recovery Scenarios (V, U, W, L)
7 Global Antiviral Drugs Treatment Market Regional Forecast, 2021-2031
7.1 Global Antiviral Drugs Treatment Market by Region Forecast 2021-2031
7.2 Global Antiviral Drugs Treatment Market Forecast by Region: Recovery Scenarios (V, U, W, L)
8 North America Antiviral Drugs Treatment Market, 2021-2031
8.1 Largest Market Share acquired by North America in Global Antiviral Drugs Treatment Market
8.2 North America Antiviral Drugs Treatment Market by Country, Forecast 2021-2031
8.3 North America Antiviral Drugs Treatment Market Forecast by Drug Class
8.3.1 North America Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031: Recovery Scenarios (V, U, W, L)
8.4 North America Antiviral Drugs Treatment Market Forecast by Application
8.4.1 North America Antiviral Drugs Treatment Market Forecast by Application, 2021-2031: Recovery Scenarios (V, U, W, L)
8.5 North America Antiviral Drugs Treatment Market Forecast by End User
8.5.1 North America Antiviral Drugs Treatment Market Forecast by End User, 2021-2031: Recovery Scenarios (V, U, W, L)
8.6 U.S. Antiviral Drugs Treatment Market Forecast, 2021-2031
8.6.1 Growing burden of Viral Diseases such as HIV, Hepatitis and Corona virus
8.6.2 Presence of Highly Developed Healthcare Infrastructure
8.6.3 U.S. Antiviral Drugs Treatment Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
8.7 Canada Antiviral Drugs Treatment Market Forecast, 2021-2031
8.7.1 Growing burden of Viral Diseases and Government support
8.7.2 Benefits of manufacturing and R&D Operations in Canada
8.7.3 Canada Antiviral Drugs Treatment Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
9 Europe Antiviral Drugs Treatment Market, 2021-2031
9.1 Increasing aging population worldwide would have a direct impact on the healthcare systems,
9.2 Europe Antiviral Drugs Treatment Market by Country, Forecast 2021-2031
9.3 Europe Antiviral Drugs Treatment Market Forecast by Drug Class
9.3.1 Europe Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031: Recovery Scenarios (V, U, W, L)
9.4 Europe Antiviral Drugs Treatment Market Forecast by Application
9.4.1 Europe Antiviral Drugs Treatment Market Forecast by Application, 2021-2031: Recovery Scenarios (V, U, W, L)
9.5 Europe Antiviral Drugs Treatment Market Forecast by End User
9.5.1 Europe Antiviral Drugs Treatment Market Forecast by End User, 2021-2031: Recovery Scenarios (V, U, W, L)
9.6 Germany Antiviral Drugs Treatment Market Forecast, 2021-2031
9.6.1 Strong Research and Development pipelines coupled with increasing product launches by the major players
9.6.2 Hepatitis A outbreaks in European Region and the Americas
9.6.3 Germany Antiviral Drugs Treatment Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
9.7 U.K. Antiviral Drugs Treatment Market Forecast, 2021-2031
9.7.1 Growing HIV Infection
9.7.2 Growing ageing population creating challenges
9.7.3 U.K. Antiviral Drugs Treatment Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
9.8 France Antiviral Drugs Treatment Market Forecast, 2021-2031
9.8.1 Growing old age population
9.8.2 Affordable Healthcare Services with Workforce Flexibility
9.8.3 France Antiviral Drugs Treatment Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
9.9 Italy Antiviral Drugs Treatment Market Forecast, 2021-2031
9.9.1 Growing Pharmaceutical Industry
9.9.2 Italy ranks amongst the countries with the maximum life expectancy worldwide
9.9.3 Italy Antiviral Drugs Treatment Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
9.10 Spain Antiviral Drugs Treatment Market Forecast, 2021-2031
9.10.1 Strongest Economy with growing pharmaceutical Industry
9.10.2 Spreading HIV in the country
9.10.3 Spain Antiviral Drugs Treatment Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
9.11 Russia Antiviral Drugs Treatment Market Forecast, 2021-2031
9.11.1 Promising Russian Pharmaceutical Industry
9.11.2 Unmet Pharmaceutical Needs
9.11.3 Russia Antiviral Drugs Treatment Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
9.12 Rest of Europe Antiviral Drugs Treatment Market Forecast, 2021-2031
9.12.1 Growing prevalence of viral infections and strategic initiatives by major market players
9.12.2 Rest of Europe Antiviral Drugs Treatment Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
10 Asia Pacific Antiviral Drugs Treatment Market, 2021-2031
10.1 Increased funding for HIV in developing countries
10.2 Asia Pacific Antiviral Drugs Treatment Market by Country, Forecast 2021-2031
10.3 Asia Pacific Antiviral Drugs Treatment Market Forecast by Drug Class
10.3.1 Asia Pacific Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031: Recovery Scenarios (V, U, W, L)
10.4 Asia Pacific Antiviral Drugs Treatment Market Forecast by Application
10.4.1 Asia Pacific Antiviral Drugs Treatment Market Forecast by Application, 2021-2031: Recovery Scenarios (V, U, W, L)
10.5 Asia Pacific Antiviral Drugs Treatment Market Forecast by End User
10.5.1 Asia Pacific Antiviral Drugs Treatment Market Forecast by End User, 2021-2031: Recovery Scenarios (V, U, W, L)
10.6 Japan Antiviral Drugs Treatment Market Forecast, 2021-2031
10.6.1 Japan Accounted for the Largest Market Share in the Asia Pacific region
10.6.2 Government Initiative
10.6.3 Japan Antiviral Drugs Treatment Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
10.7 China Antiviral Drugs Treatment Market Forecast, 2021-2031
10.7.1 Strategic initiatives taken by market Player
10.7.2 Increasing Healthcare Spending
10.7.3 China Antiviral Drugs Treatment Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
10.8 India Antiviral Drugs Treatment Market Forecast, 2021-2031
10.8.1 India has the third largest HIV epidemic in the world
10.8.2 Developing Healthcare Infrastructure
10.8.3 India Antiviral Drugs Treatment Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
10.9 Australia Antiviral Drugs Treatment Market Forecast, 2021-2031
10.9.1 Government Programme Expand Access to Quality Healthcare
10.9.2 Australia Antiviral Drugs Treatment Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
10.10 South Korea Antiviral Drugs Treatment Market Forecast, 2021-2031
10.10.1 Spreading HIV in South Korea Region
10.10.2 South Korea Antiviral Drugs Treatment Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
10.11 Rest of Asia Pacific Antiviral Drugs Treatment Market Forecast, 2021-2031
10.11.1 Growing viral infection in this Region
10.11.2 Rest of Asia Pacific Antiviral Drugs Treatment Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
11 Latin America Antiviral Drugs Treatment Market, 2021-2031
11.1 Growing Geriatric population as well as growing GDP of this region
11.2 Latin America Antiviral Drugs Treatment Market by Country, Forecast 2021-2031
11.3 Latin America Antiviral Drugs Treatment Market Forecast by Drug Class
11.3.1 Latin America Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031: Recovery Scenarios (V, U, W, L)
11.4 Latin America Antiviral Drugs Treatment Market Forecast by Application
11.4.1 Latin America Antiviral Drugs Treatment Market Forecast by Application, 2021-2031: Recovery Scenarios (V, U, W, L)
11.5 Latin America Antiviral Drugs Treatment Market Forecast by End User
11.5.1 Latin America Antiviral Drugs Treatment Market Forecast by End User, 2021-2031: Recovery Scenarios (V, U, W, L)
11.6 Brazil Antiviral Drugs Treatment Market Forecast, 2021-2031
11.6.1 Growing burden of Viral Disease in Brazil
11.6.2 Brazil Antiviral Drugs Treatment Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
11.7 Mexico Antiviral Drugs Treatment Market Forecast, 2021-2031
11.7.1 Growing Pharmaceutical Industry in Mexico
11.7.2 Recovery Scenarios (V, U, W, L): Mexico Antiviral Drugs Treatment Market Forecast, 2021-2031
11.8 Rest of Latin America Antiviral Drugs Treatment Market Forecast, 2021-2031
11.8.1 Evolving Healthcare Infrastructure
11.8.2 Government and Major market player investing in this region
11.8.3 Rest of Latin America Antiviral Drugs Treatment Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
12 Middle East and Asia Antiviral Drugs Treatment Market, 2021-2031
12.1 Middle East and Africa Antiviral Drugs Treatment Market by Country, Forecast 2021-2031
12.2 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Drug Class
12.2.1 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031: Recovery Scenarios (V, U, W, L)
12.3 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Application
12.3.1 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Application, 2021-2031: Recovery Scenarios (V, U, W, L)
12.4 Middle East and Africa Antiviral Drugs Treatment Market Forecast by End User
12.4.1 Middle East and Africa Antiviral Drugs Treatment Market Forecast by End User, 2021-2031: Recovery Scenarios (V, U, W, L)
12.5 South Africa Antiviral Drugs Treatment Market Forecast, 2021-2031
12.5.1 South Africa ranks 3rd of all new HIV Infection in Southern Africa region
12.5.2 Growing GDP and Substantial progress in the management of infectious diseases
12.5.3 South Africa Antiviral Drugs Treatment Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
12.6 GCC Antiviral Drugs Treatment Market Forecast, 2021-2031
12.6.1 Developing Healthcare Industry in this region
12.6.2 Presence of Huge Growth Opportunities
12.6.3 GCC Antiviral Drugs Treatment Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L):
12.7 Rest of Middle East and Asia Antiviral Drugs Treatment Market Forecast, 2021-2031
12.7.1 Developing Pharmaceutical Industry along with government support
12.7.2 Rest of Middle East and Africa Antiviral Drugs Treatment Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
13 Company Profiles
13.1 Company Share Analysis
13.2 Antiviral Drugs Market Recent Developments, 2017-2020
13.3 AbbVie Inc.
13.3.1 Company Snapshot
13.3.2 Company Overview
13.3.3 Financial Analysis
13.3.3.1 Net Revenue, 2015-2019
13.3.3.2 Product Revenue Shares, 2019
13.3.3.3 Regional Revenue Shares, 2019
13.3.4 Product Benchmarking
13.3.5 Recent Developments, 2017-2020
13.4 F. Hoffmann-La Roche Ltd
13.4.1 Company Snapshot
13.4.2 Company Overview
13.4.3 Financial Analysis
13.4.3.1 Net Revenue, 2015-2019
13.4.3.2 Product Revenue Shares, 2019
13.4.3.3 Regional Revenue Shares, 2019
13.4.4 Product Benchmarking
13.4.5 Recent Developments, 2017-2020
13.5 Gilead Sciences, Inc.
13.5.1 Company Snapshot
13.5.2 Company Overview
13.5.3 Financial Analysis
13.5.3.1 Net Revenue, 2015-2019
13.5.3.2 Product Revenue Shares, 2019
13.5.3.3 Regional Revenue Shares, 2019
13.5.4 Product Benchmarking
13.5.5 Recent Developments, 2017-2020
13.6 Boehringer Ingelheim International GmbH
13.6.1 Company Snapshot
13.6.2 Company Overview
13.6.3 Financial Analysis
13.6.3.1 Net Revenue, 2015-2019
13.6.3.2 Product Revenue Shares, 2019
13.6.3.3 Regional Revenue Shares, 2019
13.6.4 Product Benchmarking
13.6.5 Recent Developments, 2017-2020
13.7 AstraZeneca
13.7.1 Company Snapshot
13.7.2 Company Overview
13.7.3 Financial Analysis
13.7.3.1 Net Revenue, 2015-2019
13.7.3.2 Product Revenue Shares, 2019
13.7.3.3 Regional Revenue Shares, 2019
13.7.4 Product Benchmarking
13.7.5 Recent Developments, 2017-2020
13.8 GlaxoSmithKline plc.
13.8.1 Company Snapshot
13.8.2 Company Overview
13.8.3 Financial Analysis
13.8.3.1 Net Revenue, 2015-2019
13.8.3.2 Product Revenue Shares, 2019
13.8.3.3 Regional Revenue Shares, 2019
13.8.4 Product Benchmarking
13.8.5 Recent Developments, 2017-2020
13.9 Novartis AG
13.9.1 Company Snapshot
13.9.2 Company Overview
13.9.3 Financial Analysis
13.9.3.1 Net Revenue, 2015-2019
13.9.3.2 Product Revenue Shares, 2019
13.9.3.3 Regional Revenue Shares, 2019
13.9.4 Product Benchmarking
13.9.5 Recent Developments, 2017-2020
13.10 Merck & Co., Inc.
13.10.1 Company Snapshot
13.10.2 Company Overview
13.10.3 Financial Analysis
13.10.3.1 Net Revenue, 2015-2019
13.10.3.2 Product Revenue Shares, 2019
13.10.3.3 Regional Revenue Shares, 2019
13.10.4 Product Benchmarking
13.10.5 Recent Developments, 2017-2020
13.11 Bristol-Myers Squibb Company
13.11.1 Company Snapshot
13.11.2 Company Overview
13.11.3 Financial Analysis
13.11.3.1 Net Revenue, 2015-2019
13.11.3.2 Regional Revenue Shares, 2019
13.11.4 Product Benchmarking
13.11.5 Recent Developments, 2017-2020
13.12 Johnson & Johnson Services, Inc.
13.12.1 Company Snapshot
13.12.2 Company Overview
13.12.3 Financial Analysis
13.12.3.1 Net Revenue, 2015-2019
13.12.3.2 Product Revenue Shares, 2019
13.12.3.3 Regional Revenue Shares, 2019
13.12.4 Product Benchmarking
13.12.5 Recent Developments, 2017-2020
13.13 Cipla Inc.
13.13.1 Company Snapshot
13.13.2 Company Overview
13.13.3 Financial Analysis
13.13.3.1 Net Revenue, 2015-2019
13.13.3.2 Regional Revenue Shares, 2019
13.13.4 Product Benchmarking
13.13.5 Recent Developments, 2017-2020
13.14 Abbott.
13.14.1 Company Snapshot
13.14.2 Company Overview
13.14.3 Financial Analysis
13.14.3.1 Net Revenue, 2015-2019
13.14.3.2 Product Revenue Shares, 2019
13.14.3.3 Regional Revenue Shares, 2019
13.14.4 Product Benchmarking
14 Conclusion and Recommendations
14.1 Concluding Remarks from Visiongain
14.2 Recommendations for Market Players
List of Tables
Table 1 Global Antiviral Drugs Treatment Market Snapshot, 2021 & 2031 (US$ billion, CAGR %)
Table 2 Global Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 3 Commonly used DNA Polymerase Inhibitors
Table 4 Global Antiviral Drugs Treatment Market for Reverse Transcriptase Inhibitors Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 5 Global Antiviral Drugs Treatment Market for Reverse Transcriptase Inhibitors Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 6 Global Antiviral Drugs Treatment Market for Reverse Transcriptase Inhibitors Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 7 Global Antiviral Drugs Treatment Market for Reverse Transcriptase Inhibitors Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 8 Global Antiviral Drugs Treatment Market for Reverse Transcriptase Inhibitor Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 9 Global Antiviral Drugs Treatment Market for Protease Inhibitors Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 10 Global Antiviral Drugs Treatment Market for Protease Inhibitors Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 11 Global Antiviral Drugs Treatment Market for Protease Inhibitors Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 12 Global Antiviral Drugs Treatment Market for Protease Inhibitors Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 13 Global Antiviral Drugs Treatment Market for Protease Inhibitor Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 14 Commonly used DNA Polymerase Inhibitors
Table 15 Global Antiviral Drugs Treatment Market for DNA Polymerase Inhibitors Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 16 Global Antiviral Drugs Treatment Market for DNA Polymerase Inhibitors Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 17 Global Antiviral Drugs Treatment Market for DNA Polymerase Inhibitors Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 18 Global Antiviral Drugs Treatment Market for DNA Polymerase Inhibitors Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 19 Global Antiviral Drugs Treatment Market for DNA Polymerase Inhibitor Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 20 Commonly used Neuraminidase Inhibitor's
Table 21 Global Antiviral Drugs Treatment Market for Neuraminidase Transcriptase Inhibitors Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 22 Global Antiviral Drugs Treatment Market for Neuraminidase Inhibitors Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 23 Global Antiviral Drugs Treatment Market for Neuraminidase Inhibitors Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 24 Global Antiviral Drugs Treatment Market for Neuraminidase Inhibitors Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 25 Global Antiviral Drugs Treatment Market for Neuraminidase Inhibitor Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 26 Global Antiviral Drugs Treatment Market for Others Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR %)
Table 27 Global Antiviral Drugs Treatment Market for Others Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 28 Global Antiviral Drugs Treatment Market for Others Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 29 Global Antiviral Drugs Treatment Market for Others Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 30 Global Antiviral Drugs Treatment Market for Others Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 31 Global Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 32 Global Antiviral Drugs Treatment Market for Hepatitis Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 33 Global Antiviral Drugs Treatment Market for Hepatitis Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 34 Global Antiviral Drugs Treatment Market for Hepatitis Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 35 Global Antiviral Drugs Treatment Market for Hepatitis Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 36 Global Antiviral Drugs Treatment Market for Hepatitis Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 37 Global Antiviral Drugs Treatment Market for HIV Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 38 Global Antiviral Drugs Treatment Market for HIV Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 39 Global Antiviral Drugs Treatment Market for HIV Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 40 Global Antiviral Drugs Treatment Market for HIV Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 41 Global Antiviral Drugs Treatment Market for HIV Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 42 Global Antiviral Drugs Treatment Market for Influenza Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 43 Global Antiviral Drugs Treatment Market for Influenza Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 44 Global Antiviral Drugs Treatment Market for Influenza Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 45 Global Antiviral Drugs Treatment Market for Influenza Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 46 Global Antiviral Drugs Treatment Market for Influenza Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 47 Global Antiviral Drugs Treatment Market for Herpes Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 48 Global Antiviral Drugs Treatment Market for Herpes Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 49 Global Antiviral Drugs Treatment Market for Herpes Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 50 Global Antiviral Drugs Treatment Market for Herpes Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 51 Global Antiviral Drugs Treatment Market for Herpes Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 52 Global Antiviral Drugs Treatment Market for Others Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 53 Global Antiviral Drugs Treatment Market for Others Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 54 Global Antiviral Drugs Treatment Market for Others Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 55 Global Antiviral Drugs Treatment Market for Others Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 56 Global Antiviral Drugs Treatment Market for Others Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 57 Global Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 58 Global Antiviral Drugs Treatment Market for Hospital Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 59 Global Antiviral Drugs Treatment Market for Hospital Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 60 Global Antiviral Drugs Treatment Market for Hospital Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 61 Global Antiviral Drugs Treatment Market for Hospital Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 62 Global Antiviral Drugs Treatment Market for Hospital Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 63 Global Antiviral Drugs Treatment Market for Clinics Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 64 Global Antiviral Drugs Treatment Market for Clinics Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 65 Global Antiviral Drugs Treatment Market for Clinics Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 66 Global Antiviral Drugs Treatment Market for Clinics Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 67 Global Antiviral Drugs Treatment Market for Clinics Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 68 Global Antiviral Drugs Treatment Market for Others Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 69 Global Antiviral Drugs Treatment Market for Others Inhibitors Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 70 Global Antiviral Drugs Treatment Market for Others Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 71 Global Antiviral Drugs Treatment Market for Others Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 72 Global Antiviral Drugs Treatment Market for Others Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 73 Global Antiviral Drugs Treatment Market Forecast by Region, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 74 Global Antiviral Drugs Treatment Market Forecast by Region, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 75 Global Antiviral Drugs Treatment Market Forecast by Region, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 76 Global Antiviral Drugs Treatment Market Forecast by Region, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 77 Global Antiviral Drugs Treatment Market Forecast by Region, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 78 North America Antiviral Drugs Treatment Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 79 North America Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 80 North America Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 81 North America Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 82 North America Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 83 North America Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 84 North America Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 85 North America Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 86 North America Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 87 North America Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 88 North America Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 89 North America Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 90 North America Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 91 North America Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 92 North America Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 93 North America Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 94 U.S. Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 95 U.S. Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 96 U.S. Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 97 U.S. Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 98 U.S. Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 99 Canada Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 100 Canada Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 101 Canada Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 102 Canada Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 103 Canada Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 104 Europe Antiviral Drugs Treatment Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 105 Europe Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 106 Europe Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 107 Europe Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 108 Europe Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 109 Europe Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 110 Europe Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 111 Europe Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 112 Europe Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 113 Europe Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 114 Europe Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 115 Europe Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 116 Europe Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 117 Europe Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 118 Europe Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 119 Europe Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 120 Germany Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR %)
Table 121 Germany Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 122 Germany Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 123 Germany Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 124 Germany Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 125 U.K. Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 126 U.K. Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 127 U.K. Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 128 U.K. Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 129 U.K. Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 130 France Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 131 France Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 132 France Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 133 France Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 134 France Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 135 Italy Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 136 Italy Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 137 Italy Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 138 Italy Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 139 Italy Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 140 Spain Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 141 Spain Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 142 Spain Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 143 Spain Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 144 Spain Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 145 Russia Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 146 Russia Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 147 Russia Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 148 Russia Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 149 Russia Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 150 Rest of Europe Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 151 Rest of Europe Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 152 Rest of Europe Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 153 Rest of Europe Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 154 Rest of Europe Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 155 Asia Pacific Antiviral Drugs Treatment Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 156 Asia Pacific Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 157 Asia Pacific Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 158 Asia Pacific Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 159 Asia Pacific Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 160 Asia Pacific Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 161 Asia Pacific Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR %)
Table 162 Asia Pacific Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 163 Asia Pacific Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 164 Asia Pacific Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 165 Asia Pacific Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 166 Asia Pacific Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 167 Asia Pacific Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 168 Asia Pacific Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 169 Asia Pacific Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 170 Asia Pacific Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 171 Japan Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 172 Japan Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 173 Japan Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 174 Japan Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 175 Japan Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 176 China Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 177 China Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 178 China Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 179 China Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 180 China Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 181 India Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 182 India Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 183 India Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 184 India Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 185 India Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 186 Australia Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 187 Australia Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 188 Australia Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 189 Australia Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 190 Australia Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 191 South Korea Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 192 South Korea Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 193 South Korea Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 194 South Korea Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 195 South Korea Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 196 Rest of Asia Pacific Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 197 Rest of Asia Pacific Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 198 Rest of Asia Pacific Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 199 Rest of Asia Pacific Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 200 Rest of Asia Pacific Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 201 Latin America Antiviral Drugs Treatment Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 202 Latin America Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 203 Latin America Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 204 Latin America Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 205 Latin America Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 206 Latin America Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 207 Latin America Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 208 Latin America Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 209 Latin America Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 210 Latin America Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 211 Latin America Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 212 Latin America Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 213 Latin America Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 214 Latin America Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 215 Latin America Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 216 Latin America Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 217 Brazil Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 218 Brazil Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 219 Brazil Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 220 Brazil Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 221 Brazil Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 222 Mexico Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR %)
Table 223 Mexico Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 224 Mexico Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 225 Mexico Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 226 Mexico Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 227 Rest of Latin America Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 228 Rest of Latin America Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 229 Rest of Latin America Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 230 Rest of Latin America Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 231 Rest of Latin America Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 232 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 233 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 234 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 235 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 236 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 237 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 238 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 239 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 240 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 241 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 242 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 243 Middle East and Africa Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 244 Middle East and Africa Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 245 Middle East and Africa Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 246 Middle East and Africa Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 247 Middle East and Africa Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 248 South Africa Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 249 South Africa Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 250 South Africa Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 251 South Africa Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 252 South Africa Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 253 GCC Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 254 GCC Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 255 GCC Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 256 GCC Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 257 GCC Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 258 Rest of Middle East and Africa Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 259 Rest of Middle East and Africa Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 260 Rest of Middle East and Africa Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 261 Rest of Middle East and Africa Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 262 Rest of Middle East and Africa Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 263 Antiviral Drugs Market Recent Developments, 2017-2020
Table 264 AbbVie Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 265 AbbVie Inc.: Product Benchmarking
Table 266 AbbVie Inc.: Recent Developments, 2017-2020
Table 267 F. Hoffmann-La Roche Ltd: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 268 F. Hoffmann-La Roche Ltd. .: Product Benchmarking
Table 269 F. Hoffmann -La Roche Ltd. : Recent Developments, 2017-2020
Table 270 Gilead Sciences, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 271 Gilead Sciences, Inc. Product Benchmarking
Table 272 Gilead Sciences Inc. Recent Developments, 2017-2020
Table 273 Boehringer Ingelheim International GmbH: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 274 Boehringer Ingelheim International GmbH: Product Benchmarking
Table 275 Boehringer Ingelheim International GmbH; Recent Developments, 2017-2020
Table 276 AstraZeneca: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 277 AstraZeneca; Product Benchmarking
Table 278 AstraZeneca Recent Developments, 2017-2020
Table 279 GlaxoSmithKline plc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 280 GlaxoSmithKline plc.; Product Benchmarking
Table 281 GlaxoSmithKline plc.: Recent Developments, 2017-2020
Table 282 Novartis AG : Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 283 Novartis AG: Product Benchmarking
Table 284 Novartis AG: Recent Developments, 2017-2020
Table 285 Merck & Co., Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 286 Merck & Co., Inc.: Product Benchmarking
Table 287 Merck & Co., Inc.: Recent Developments, 2017-2020
Table 288 Bristol-Myers Squibb Company: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 289 Bristol-Myers Squibb Company: Product Benchmarking
Table 290 Bristol-Myers Squibb Company: Recent Developments, 2017-2020
Table 291 Johnson & Johnson Services, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 292 Johnson & Johnson Services, Inc.: Product Benchmarking
Table 293 Johnson & Johnson Services, Inc.: Recent Developments, 2017-2020
Table 294 Cipla Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 295 Cipla Inc.: Product Benchmarking
Table 296 Cipla Inc.: Recent Developments, 2017-2020
Table 297 Abbott: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 298 Abbott: Product Benchmarking
List of Figures
Figure 1 Global Anti-Viral Drugs Market Size Forecast 2021-2031 (US$Bn, AGR %)
Figure 2 Global Antiviral Drugs Treatment Market Segmentation
Figure 3 Global Antiviral Drugs Treatment Market: Market Trends
Figure 4 Global Antiviral Drugs Treatment Market: Porter's Five Forces Analysis
Figure 5 Global Antiviral Drugs Treatment Market: PEST Analysis
Figure 6 Global Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ billion, AGR %)
Figure 7 Global Antiviral Drugs Treatment Market Share Forecast by Drug Class, 2021, 2026, 2031 (%)
Figure 8 Global Antiviral Drugs Treatment Market for Reverse Transcriptase Inhibitors Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 9 Global Antiviral Drugs Treatment Market for Reverse Transcriptase Inhibitors Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 10 Global Antiviral Drugs Treatment Market for Reverse Transcriptase Inhibitors Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 11 Global Antiviral Drugs Treatment Market for Reverse Transcriptase Inhibitor Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 12 Global Antiviral Drugs Treatment Market for Reverse Transcriptase Inhibitor Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 13 Global Antiviral Drugs Treatment Market for Protease Inhibitors Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 14 Global Antiviral Drugs Treatment Market for Protease Inhibitors Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 15 Global Antiviral Drugs Treatment Market for Protease Inhibitors Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 16 Global Antiviral Drugs Treatment Market for Protease Inhibitor Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 17 Global Antiviral Drugs Treatment Market for Protease Inhibitor Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 18 Global Antiviral Drugs Treatment Market for DNA Polymerase Inhibitors Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 19 Global Antiviral Drugs Treatment Market for DNA Polymerase Inhibitors Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 20 Global Antiviral Drugs Treatment Market for DNA Polymerase Inhibitors Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 21 Global Antiviral Drugs Treatment Market for DNA Polymerase Inhibitor Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 22 Global Antiviral Drugs Treatment Market for DNA Polymerase Inhibitor Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 23 Global Antiviral Drugs Treatment Market for Neuraminidase Inhibitors Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 24 Global Antiviral Drugs Treatment Market for Neuraminidase Inhibitors Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 25 Global Antiviral Drugs Treatment Market for Neuraminidase Inhibitors Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 26 Global Antiviral Drugs Treatment Market for Neuraminidase Inhibitor Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 27 Global Antiviral Drugs Treatment Market for Neuraminidase Inhibitor Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 28 Global Antiviral Drugs Treatment Market for Others Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 29 Global Antiviral Drugs Treatment Market for Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 30 Global Antiviral Drugs Treatment Market for Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 31 Global Antiviral Drugs Treatment Market for Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 32 Global Antiviral Drugs Treatment Market for Others Se
